(Q72386190)
Statements
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer (English)
T Shinkai
H Arioka
H Kunikane
K Eguchi
Y Sasaki
T Tamura
Y Ohe
F Oshita
M Nishio